How the Coronavirus Pandemic Is Breaking Artificial Intelligence and How to Fix It – Gizmodo

As covid-19 disrupted the world in March, online retail giant Amazon struggled to respond to the sudden shift caused by the pandemic. Household items like bottled water and toilet paper, which never ran out of stock, suddenly became in short supply. One- and two-day deliveries were delayed for several days. Though Amazon CEO Jeff Bezos would go on to make $24 billion during the pandemic, initially, the company struggled with adjusting its logistics, transportation, supply chain, purchasing, and third-party seller processes to prioritize stocking and delivering higher-priority items.

Under normal circumstances, Amazons complicated logistics are mostly handled by artificial intelligence algorithms. Honed on billions of sales and deliveries, these systems accurately predict how much of each item will be sold, when to replenish stock at fulfillment centers, and how to bundle deliveries to minimize travel distances. But as the coronavirus pandemic crisis has changed our daily habits and life patterns, those predictions are no longer valid.

In the CPG [consumer packaged goods] industry, the consumer buying patterns during this pandemic has shifted immensely, Rajeev Sharma, SVP and global head of enterprise AI solutions & cognitive engineering at AI consultancy firm Pactera Edge, told Gizmodo. There is a tendency of panic buying of items in larger quantities and of different sizes and quantities. The [AI] models may have never seen such spikes in the past and hence would give less accurate outputs.

Artificial intelligence algorithms are behind many changes to our daily lives in the past decades. They keep spam out of our inboxes and violent content off social media, with mixed results. They fight fraud and money laundering in banks. They help investors make trade decisions and, terrifyingly, assist recruiters in reviewing job applications. And they do all of this millions of times per day, with high efficiencymost of the time. But they are prone to becoming unreliable when rare events like the covid-19 pandemic happen.

Among the many things the coronavirus outbreak has highlighted is how fragile our AI systems are. And as automation continues to become a bigger part of everything we do, we need new approaches to ensure our AI systems remain robust in face of black swan events that cause widespread disruptions.

Key to the commercial success of AI is advances in machine learning, a category of algorithms that develop their behavior by finding and exploiting patterns in very large sets of data. Machine learning and its more popular subset deep learning have been around for decades, but their use had previously been limited due to their intensive data and computational requirements. In the past decade, the abundance of data and advances in processor technology have enabled companies to use machine learning algorithms in new domains such as computer vision, speech recognition, and natural language processing.

When trained on huge data sets, machine learning algorithms often ferret out subtle correlations between data points that would have gone unnoticed to human analysts. These patterns enable them to make forecasts and predictions that are useful most of the time for their designated purpose, even if theyre not always logical. For instance, a machine-learning algorithm that predicts customer behavior might discover that people who eat out at restaurants more often are more likely to shop at a particular kind of grocery store, or maybe customers who shop online a lot are more likely to buy certain brands.

All of those correlations between different variables of the economy are ripe for use by machine learning models, which can leverage them to make better predictions. But those correlations can be ephemeral, and highly context-dependent, David Cox, IBM director at the MIT-IBM Watson AI Lab, told Gizmodo. What happens when the ground conditions change, as they just did globally when covid-19 hit? Customer behavior has radically changed, and many of those old correlations no longer hold. How often you eat out no longer predicts where youll buy groceries, because dramatically fewer people eat out.

As consumers change their habits, the intrinsic correlations between the myriad variables that define the behavior of a supply chain fall apart, and those old prediction models lose their relevance. This can result in depleted warehouses and delayed deliveries on a large scale, as Amazon and other companies have experienced. If your predictions are based on these correlations, without an understanding of the underlying causes and effects that drive those correlations, your predictions will be wrong, said Cox.

The same impact is visible in other areas, such as banking, where machine learning algorithms are tuned to detect and flag sudden changes to the spending habits of customers as possible signs of compromised accounts. According to Teradata, a provider of analytics and machine learning services, one of the companies using its platform to score high-risk transactions saw a fifteen-fold increase in mobile payments as consumers started spending more online and less in physical stores. (Teradata did not disclose the name of the company as a matter of policy.) Fraud-detection algorithms search for anomalies in customer behavior, and such sudden shifts can cause them to flag legitimate transactions as fraudulent. According to the firm, it was able to maintain the accuracy of its banking algorithms and adapt them to the sudden shifts caused by the lockdown.

But the disruption was more fundamental in other areas such as computer vision systems, the algorithms used to detect objects and people in images.

Weve seen several changes in underlying data due to covid-19, which has had an impact on performances of individual AI models as well as end-to-end AI pipelines, said Atif Kureishy, VP of global emerging practices, artificial intelligence and deep learning for Teradata. As people start wearing masks due to the covid-19, we have seen performance decay as facial coverings introduce missed detections in our models.

Teradatas Retail Vision technology uses deep learning models trained on thousands of images to detect and localize people in the video streams of in-store cameras. With powerful and potentially ominous capabilities, the AI also analyzes the video for information such as peoples activities and emotions, and combines it with other data to provide new insights to retailers. The systems performance is closely tied to being able to locate faces in videos, but with most people wearing masks, the AIs performance has seen a dramatic performance drop.

In general, machine and deep learning give us very accurate-yet-shallow models that are very sensitive to changes, whether it is different environmental conditions or panic-driven purchasing behavior by banking customers, Kureishy said.

We humans can extract the underlying rules from the data we observe in the wild. We think in terms of causes and effects, and we apply our mental model of how the world works to understand and adapt to situations we havent seen before.

If you see a car drive off a bridge into the water, you dont need to have seen an accident like that before to predict how it will behave, Cox said. You know something (at least intuitively) about why things float, and you know things about what the car is made of and how it is put together, and you can reason that the car will probably float for a bit, but will eventually take on water and sink.

Machine learning algorithms, on the other hand, can fill the space between the things theyve already seen, but cant discover the underlying rules and causal models that govern their environment. They work fine as long as the new data is not too different from the old one, but as soon as their environment undergoes a radical change, they start to break.

Our machine learning and deep learning models tend to be great at interpolationworking with data that is similar to, but not quite the same as data weve seen beforebut they are often terrible at extrapolationmaking predictions from situations that are outside of their experience, Cox says.

The lack of causal models is an endemic problem in the machine learning community and causes errors regularly. This is what causes Teslas in self-driving mode to crash into concrete barriers and Amazons now-abandoned AI-powered hiring tool to penalize a job applicant for putting womens chess club captain in her resume.

A stark and painful example of AIs failure to understand context happened in March 2019, when a terrorist live-streamed the massacre of 51 people in New Zealand on Facebook. The social networks AI algorithm that moderates violent content failed to detect the gruesome video because it was shot in first-person perspective, and the algorithms had not been trained on similar content. It was taken down manually, and the company struggled to keep it off the platform as users reposted copies of it.

Major events like the global pandemic can have a much more detrimental effect because they trigger these weaknesses in a lot of automated systems, causing all sorts of failures at the same time.

It is imperative to understand that the AI/ML models trained on consumer behavior data are bound to suffer in terms of their accuracy of prediction and potency of recommendations under a black swan event like the pandemic, said Pacteras Sharma. This is because the AI/ML models may have never seen that kind of shifts in the features that are used to train them. Every AI platform engineer is fully aware of this.

This doesnt mean that the AI models are wrong or erroneous, Sharma pointed out, but implied that they need to be continuously trained on new data and scenarios. We also need to understand and address the limits of the AI systems we deploy in businesses and organizations.

Sharma described, for example, an AI that classifies credit applications as Good Credit or Bad Credit and passes on the rating to another automated system that approves or rejects applications. If owing to some situations (like this pandemic), there is a surge in the number of applicants with poor credentials, Sharma said, the models may have a challenge in their ability to rate with high accuracy.

As the worlds corporations increasingly turn to automated, AI-powered solutions for deciding the fate of their human clients, even when working as designed, these systems can have devastating implications for those applying for credit. In this case, however, the automated system would need to be explicitly adjusted to deal with the new rules, or the final decisions can be deferred to a human expert to prevent the organization from accruing high risk clients on its books.

Under the present circumstances of the pandemic, where model accuracy or recommendations no longer hold true, the downstream automated processes may need to be put through a speed breaker like a human-in-the-loop for added due diligence, he said.

IBMs Cox believes if we manage to integrate our own understanding of the world into AI systems, they will be able to handle black swan events like the covid-19 outbreak.

We must build systems that actually model the causal structure of the world, so that they are able to cope with a rapidly changing world and solve problems in more flexible ways, he said.

MIT-IBM Watson AI Lab, where Cox works, has been working on neurosymbolic systems that bring together deep learning with classic, symbolic AI techniques. In symbolic AI, human programmers explicitly specify the rules and details of the systems behavior instead of training it on data. Symbolic AI was dominant before the rise of deep learning and is better suited for environments where the rules are clearcut. On the other hand, it lacks the ability of deep learning systems to deal with unstructured data such as images and text documents.

The combination of symbolic AI and machine learning has helped create systems that can learn from the world, but also use logic and reasoning to solve problems, Cox said.

IBMs neurosymbolic AI is still in the research and experimentation stage. The company is testing it in several domains, including banking.

Teradatas Kureishy pointed to another problem that is plaguing the AI community: labeled data. Most machine learning systems are supervised, which means before they can perform their functions, they need to be trained on huge amounts of data annotated by humans. As conditions change, the machine learning models need new labeled data to adjust themselves to new situations.

Kureishy suggested that the use of active learning can, to a degree, help address the problem. In active learning models, human operators are constantly monitoring the performance of machine learning algorithms and provide them with new labeled data in areas where their performance starts to degrade. These active learning activities require both human-in-the-loop and alarms for human intervention to choose what data needs to be relabeled, based on quality constraints, Kureishy said.

But as automated systems continue to expand, human efforts fail to meet the growing demand for labeled data. The rise of data-hungry deep learning systems has given birth to a multibillion-dollar data-labeling industry, often powered by digital sweatshops with underpaid workers in poor countries. And the industry still struggles to create enough annotated data to keep machine learning models up to date. We will need deep learning systems that can learn from new data with little or no help from humans.

As supervised learning models are more common in the enterprise, they need to be data-efficient so that they can adapt much faster to changing behaviors, Kureishy said. If we keep relying on humans to provide labeled data, AI adaptation to novel situations will always be bounded by how fast humans can provide those labels.

Deep learning models that need little or no manually labeled data is an active area of AI research. In last years AAAI Conference, deep learning pioneer Yann LeCun discussed progress in self-supervised learning, a type of deep learning algorithm that, like a child, can explore the world by itself without being specifically instructed on every single detail.

I think self-supervised learning is the future. This is whats going to allow our AI systems to go to the next level, perhaps learn enough background knowledge about the world by observation, so that some sort of common sense may emerge, LeCun said in his speech at the conference.

But as is the norm in the AI industry, it takes yearsif not decadesbefore such efforts become commercially viable products. In the meantime, we need to acknowledge and embrace the power and limits of current AI.

These are not your static IT systems, Sharma says. Enterprise AI solutions are never done. They need constant re-training. They are living, breathing engines sitting in the infrastructure. It would be wrong to assume that you build an AI platform and walk away.

Ben Dickson is a software engineer, tech analyst, and the founder of TechTalks.

See the article here:

How the Coronavirus Pandemic Is Breaking Artificial Intelligence and How to Fix It - Gizmodo

R3 Stem Cell International Now Offering Four Joint Injections for Only $3950 in Mexico – Yahoo Finance

R3 Stem Cell International is now offering patients the opportunity to receive four stem cell joint injections for only $3950. With 50 million stem cells total, patients may choose which extremities they would like treated.

SCOTTSDALE, Ariz., July 29, 2020 /PRNewswire-PRWeb/ -- R3 Stem Cell International is now offering patients the opportunity to receive four stem cell joint injections for only $3950. With 50 million stem cells total, patients may choose which extremities they would like treated.

Several studies have shown just how well stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab with a long history of accreditation and pristine safety record. The lab abides by quality assurance standards that exceed those of the FDA.

Stem cell treatment for knees in Mexico at R3 works amazingly well. Patient satisfaction surveys at the center reveal that nine out of ten patients say they would have the procedure again and recommend it to friends and family.

According to R3 CEO David Greene, MD, MBA, "The biologics don't need preservative and viability exceeds 95%. The pureness and potency truly makes the difference in outcomes. Four joints for under $4000? What we put together for patients is incredible!"

The treatment process begins with a free phone consultation with one of R3's licensed, experienced stem cell doctors. Because the treatment includes 50 million stem cells, four joints may be included. The dedicated patient concierge representative assists with travel logistics. Travel from San Diego is included to the clinic, which is only 20 minutes from the San Diego airport.

Image guidance is used at the Center to ensure injection accuracy. In addition to arthritis treatment, R3 International offers stem cell treatment for autism, Lyme, COPD, kidney failure, neuropathy, diabetes, MS, ALS, stroke and much more.

Call (888) 988-0515 to learn more about therapies offered, and visit https://stemcelltreatmentclinic.com to read about the process.

SOURCE R3 Stem Cell International

More here:

R3 Stem Cell International Now Offering Four Joint Injections for Only $3950 in Mexico - Yahoo Finance

Industry News: Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy – SelectScience

Collaboration to develop stem cell therapies for COVID-19 and future pandemic diseases

Avacta Group plc , the developer of Affimer biotherapeutics and reagents, has announced an expansion of its collaboration and license agreement with Daewoong Pharmaceutical Co. Ltd. and AffyXell Therapeutics, the joint venture established in South Korea by the two companies, to develop stem cell treatments incorporating Avactas neutralizing Affimer therapy for the treatment of seriously ill patients with COVID-19 and to also prepare to rapidly develop similar therapies for future global pandemics.

Respiratory diseases such as COVID-19 can cause serious damage to the lungs as a consequence of over-activation of the patient's immune system, resulting in cytokine release syndrome that can potentially lead to multiple organ failure and death. Stem cell therapies offer a very promising approach to repair the damage to lung tissues in these pulmonary diseases by controlling the immune balance.

AffyXell Therapeutics, the next-generation cell and gene therapy joint venture between Avacta and Daewoong Pharmaceutical, is developing a novel class of mesenchymal stem cell (MSC) treatments that are engineered to also produce Affimer therapies in the patient at the site of action.

The expansion of the agreement between Avacta, Daewoong Pharmaceutical and AffyXell announced today extends the scope of the partnership to include Affimer molecules that target viruses, such as coronaviruses, in order to develop therapies that repair the lung damage caused by COVID-19 whilst also producing neutralizing Affimer molecules to prevent the progression of the disease.

AffyXell will engineer mesenchymal stem cells to express SARS-COV-2 neutralizing Affimer molecules in order to develop treatments for seriously ill COVID-19 patients, and will also prepare for rapid development of next-generation stem cell therapies for future infectious respiratory disease outbreaks.

Dr. Alastair Smith, Chief Executive of Avacta Group commented: I am very pleased to have extended our collaboration and license agreement with Daewoong Pharmaceutical to include the SARS-COV-2 neutralizing Affimer molecules for the treatment of COVID-19 and to create the potential to respond very rapidly in future to global virus threats.

AffyXell will address the need over the coming years for advanced stem cell therapies to treat lung damage caused by cytokine release syndrome suffered by COVID-19 patients and, at the same time, help prevent disease progression in these patients through the action of a neutralizing Affimer therapy.

More broadly, one of the key areas of unmet clinical need that AffyXell can address with its next-generation mesenchymal stem cell therapies is acute pulmonary diseases such as COPD and acute respiratory distress syndrome. We, and our partners in South Korea, are very excited by the potential to develop life-improving treatments for patients with these serious respiratory diseases as well as COVID-19.

I look forward to further updating the market on progress in our ground-breaking programs with AffyXell in due course, and on progress with our COVID-19 diagnostics programs shortly.

Seng-ho Jeon, CEO of Daewoong Pharmaceutical and AffyXell Therapeutics, commented:It is very encouraging that AffyXell now has the opportunity to expand the application of its next-generation stem cell platform technology to target viruses. The SARS-COV-2 neutralizing Affimer to be developed in combination with AffyXells cell and gene technology is expected to be an innovative solution for COVID-19 patients suffering cytokine release syndrome.

Daewoong has been also conducting several research programs and clinical trial for COVID-19. As the COVID-19 crisis has caused great difficulties worldwide, we will continue to focus our efforts to develop a novel therapeutic agent for COVID-19.

Want more of the latest science news straight to your inbox?Become a SelectScience member for free today>>

Read the original here:

Industry News: Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy - SelectScience

$30+ Billion Cell Expansion Market by Product, Cell Type, Application, End-user and Region – Forecast to 2025 – ResearchAndMarkets.com – Yahoo Finance

The "Cell Expansion Market by Product (Reagent, Media, Flow Cytometer, Centrifuge, Bioreactor), Cell Type (Human, Animal), Application (Regenerative Medicine & Stem Cell Research, Cancer & Cell-based Research), End-User, and Region - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.

The global cell expansion market is projected to reach USD 30.06 billion by 2025 from an estimated USD 14.91 billion in 2020, at a CAGR of 15.1%.

The report segments the cell expansion market based on region (Asia Pacific, Europe, North America, and RoW), product (consumables and instruments), cell type (human cells and animal cells), application (regenerative medicine and stem cell research, cancer and cell-based research and other applications), and end user (research institutes, biotechnology and biopharmaceutical companies, cell banks, and other end users). The report also provides a comprehensive review of market drivers, restraints, and opportunities in the cell expansion market.

Increasing incidence of chronic diseases and government investments for cell-based research are set to drive the cell expansion market

Growth in this market is largely driven by the increasing incidence of chronic diseases, government investments for cell-based research, growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and increasing GMP certifications for cell therapy production facilities. On the other hand, ethical concerns regarding research in cell biology are expected to limit market growth to a certain extent in the coming years.

By instruments type, the cell expansion supporting equipment accounted for the fasted growing product segment of the cell expansion market

The instruments segment includes cell expansion supporting equipment, bioreactors, and automated cell expansion systems. The cell expansion supporting equipment market includes flow cytometers, cell counters and hemocytometers, centrifuges, and other supporting equipment. They are used in cell culture processes for isolating, culturing, scaling-up, and extracting biological products. These instruments are essential in laboratories and institutes for conducting research and analyzing the cell structure and function for cell therapy research.

By cell type, the human cells segment accounted for the largest share of the cell expansion market

Based on cell type, the cell expansion market is segmented into human cells and animal cells. The human cells segment includes stem cells and differentiated cells. The stem cells segment is further classified into adult stem cells, ESCs, and iPSCs. The human cells segment accounted for the larger share of the cell expansion market majorly due to the increasing investments by public and private organizations for research on human cells, growing application areas of human stem cells, and the growing incidence of diseases such as cancer.

Asia Pacific: The fastest-growing region in the cell expansion market

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the increasing focus of players on emerging Asian markets, increasing incidence of chronic and infectious diseases, rising geriatric population, and government initiatives for infrastructural improvements of healthcare facilities are driving the growth of the cell expansion market in this region.

North America: the largest share of the cell expansion market

North America accounted for the largest share of the cell expansion market. The large share of this segment can primarily be attributed to the rising incidence of cancer, increasing government funding, rising research activates on stem cell therapies, growing awareness regarding advanced treatment methods, growing geriatric population, and the strong presence of industry players in the region.

Company Profiles

Established Companies

Start-up Companies

For more information about this report visit https://www.researchandmarkets.com/r/y35ufs

View source version on businesswire.com: https://www.businesswire.com/news/home/20200729005450/en/

Contacts

ResearchAndMarkets.comLaura Wood, Senior Press Managerpress@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT Office Hours Call +353-1-416-8900

More:

$30+ Billion Cell Expansion Market by Product, Cell Type, Application, End-user and Region - Forecast to 2025 - ResearchAndMarkets.com - Yahoo Finance

Global Stem Cell Therapy Market 2020 Analysis by Geographical Regions, Type and Application Till 2027 – Market Research Posts

This latest report studies Stem Cell Therapy Market globally, particularly in North America, Europe(Germany, UK, France, Italy, Spain, Russia, Poland), China, Japan, Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam) the Middle East and Africa(Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria), India, South America(Brazil, Mexico, Colombia), with revenue, import, and export, production, consumption in these regions, from 2015 to 2019, and forecast 2020 to 2027. Global Stem Cell Therapy market 2020 research report is replete with precise analysis from radical studies, specifically on queries that approach market size, trends, share, forecast, outlook, production, and futuristic developments trends and present and future market status.

Then, the report focuses on world major leading industry players with information like company profiles, product picture and specifications, Sales Revenue, Price, gross margin, market share, and contact info. In addition, the Stem Cell Therapy industry development trends and marketing channels are analyzed.

Request For Free Sample Report:

https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#request_sample

Analysis of Stem Cell Therapy market Key manufacturers (Sales Revenue, Price, gross margin, main products, etc.):

Celgene CorporationOsiris Therapeutics, Inc.Pharmicell Co., LtdMEDIPOST Co., Ltd.Promethera BiosciencesFibrocell Science, Inc.Holostem Terapie Avanzate S.r.l.Cytori TherapeuticsNuvasive, Inc.RTI Surgical, Inc.Anterogen Co., Ltd.RTI Surgical, Inc

Analysis of Stem Cell Therapy Market By Product Types(Market Size & Forecast):

Adult Stem CellsHuman EmbryonicInduced Pluripotent Stem CellsVery Small Embryonic Like Stem Cells

Analysis of Stem Cell Therapy Market By Applications(Market Size & Forecast):

Regenerative MedicineDrug Discovery and Development

In additional, the manufacturers dominant within the global Stem Cell Therapy Market are highlighted inside the competitive landscape section of the report. The competitive state of affairs and trends current within the market have additionally been encapsulated underneath this section of the study. moreover, the mergers and acquisitions that passed off within the market in the past few years and their impact on the markets development has in addition been bestowed underneath this a part of the report.

Ask For Discount: https://www.reportspedia.com/discount_inquiry/discount/57925

Furthermore, it describes the in-depth analysis of key Stem Cell Therapy market segments and sub-segments, particularly includes evolving Stem Cell Therapy industry trends and dynamics, challenges, and competitive insights, technological breakthroughs for Stem Cell Therapy market development mapping with different opportunities. The report also analyzes the Stem Cell Therapy industry potential for every geographical region consequently.

With the list of tables and figures, the report provides key statistics on the condition of the business and could be a valuable supply of steerage and direction for firms and people curious about the market.

Any Query Or Specific Requirement? Ask to our Research expert @

https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#inquiry_before_buying

TOC of Stem Cell Therapy Market Contains Following Points:

Table of Content & Table Of Figures

https://www.reportspedia.com/report/business-services/2015-2027-global-stem-cell-therapy-industry-market-research-report,-segment-by-player,-type,-application,-marketing-channel,-and-region/57925#table_of_contents

Here is the original post:

Global Stem Cell Therapy Market 2020 Analysis by Geographical Regions, Type and Application Till 2027 - Market Research Posts

Arson at The Way Christian Center and The Shortage of Stem Cell Donors of Color – KPFA – 94.1FM

Davey D brings us audio from todays press conference held at The Way Christian Center in Berkeley Ca. Less than 12 hours after The Way Christian Center placed a Black Lives Matter banner, someone set fire to several trash cans positioned at the back of the church. The act of arson, damaged a portion of the building (see photos below) and has created fear and anger in the community.

Later we speak with Jess Tom and Carol Gillespie about treatment for blood-related cancers, the shortage of stem cell donors of color and the need to improve the registries. Seventy percent of patients wont have a match in their families and must find an unrelated donor. Patients are more likely to match donors who share the same ethnic background, but the lack of diversity on the Be The Match national registry makes it difficult for patients to find one. The Asian American Donor Program (AADP, https://www.aadp.org), a nonprofit organization in Alameda, is urging individuals to register as a potential stem cell donor. Join the registry by texting AADP to 61474

Guests:

Pastor Michael McBride (known as Pastor Mike) The fire was an act of terror, said Pastor Michael McBride, who leads the 48-year-old Way Christian Church.

Pastor Michael McBride is a native of San Francisco, CA. and has been active in ministry for almost 20 years. In June 2005, Pastor McBridelaunched a new ministry, The Way Christian Center in West Berkeley, where he presently serves as thePastor.

Carol Gillespie, Executive Director, Asian American Donor Program

Carol Gillespie is one of the original members of the Board of Directors for the Asian American Donor Program (AADP) when it was founded in 1989. She volunteered for AADP for3 years before accepting the position as Project Administrator in 1992. In 2002, Gillespie was selected as AADPs Executive Director and is currently serving in that position.

Jess Tom, Chef, Author, and TV Guest

Jess Tom is the sister of Andrew, who at 29 years old was living his dream and engaged to the love of his life. In May 2020 Andrew went to the doctor for swollen lymph nodes. A couple of days later, he was diagnosed withmixed phenotype acute leukemia (MPAL), a rare and aggressive form of leukemia. MPAL accounts for only 2-5% of all leukemias. The only way he can beat the illness is with a stem cell transplant.

In order to have a stem cell transplant, first a stem cell match for Andrew must be found. No one in Andrews family is a match. As being a match is genetically based, Andrews stem cell match will most likely be someone who is Chinese.Chinese donors only make up 0.7% of the national donor registry, leaving him with only a 43% chance of finding a perfect match.

Jess Tom has been working with the Asian American Donor Program, a nonprofit organization, to encourage Chinese Americans to register as potential stem cell donors. Sheis a chef and winner of season 14 ofFood Network Star. Jess Tom is a writer and food blogger living in Brooklyn.

She is the author ofFOOD WHORE: A Novel of Dining & Deceitpublished by William Morrow/HarperCollins. The paperback edition was released in 2015.FOOD WHORE, Jess first novel, merges her love of food and fiction.

You can find Jess on stage, online and on television, appearing on the Food Network, Good Morning America, the Today Show, and more.She has worked on initiatives with food trucks, restaurants, hospitality startups, and citywide culinary programs.

Excerpt from:

Arson at The Way Christian Center and The Shortage of Stem Cell Donors of Color - KPFA - 94.1FM

Canine Stem Cell Therapy Market Segment Analysis by Leading Players, Drivers, Regional, Competitive Landscape & Forecast To 2019 2029 – Owned

A synopsis of the global canine stem cell therapy market with reference to the global healthcare pharmaceutical industry

Despite the economic and political uncertainty in the recent past, the global healthcare industry has been receiving positive nudges from reformative and technological disruptions in medical devices, pharmaceuticals and biotech, in-vitro diagnostics, and medical imaging. Key markets across the world are facing a massive rise in demand for critical care services that are pushing global healthcare spending levels to unimaginable limits.

A rapidly multiplying geriatric population; increasing prevalence of chronic ailments such as cancer and cardiac disease; growing awareness among patients; and heavy investments in clinical innovation are just some of the factors that are impacting the performance of the global healthcare industry. Proactive measures such as healthcare cost containment, primary care delivery, innovation in medical procedures (3-D printing, blockchain, and robotic surgery to name a few), safe and effective drug delivery, and well-defined healthcare regulatory compliance models are targeted at placing the sector on a high growth trajectory across key regional markets.

Parent Indicators Healthcare Current expenditure on health, % of gross domestic product Current expenditure on health, per capita, US$ purchasing power parities (current prices, current PPPs) Annual growth rate of current expenditure on health, per capita, in real terms Out-of-pocket expenditure, % of current expenditure on health Out-of-pocket expenditure, per capita, US$ purchasing power parity (current prices, current PPPs) Physicians, Density per 1000 population (head counts) Nurses, Density per 1000 population (head counts) Total hospital beds, per 1000 population Curative (acute) care beds, per 1000 population Medical technology, Magnetic Resonance Imaging units, total, per million population Medical technology, Computed Tomography scanners, total, per million population

Research Methodology

This Press Release will help you to understand the Volume, growth with Impacting Trends. Click HERE To get SAMPLE PDF (Including Full TOC, Table & Figures) athttps://www.xploremr.com/connectus/sample/2360

XploreMR utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, to obtain precise market estimations and insights on Molecule and Drug Classes, API Formulations and preferred modes of administration. Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.

Request Report Methodology at https://www.xploremr.com/connectus/request-methodology/2360

Standard Report Structure Executive Summary Market Definition Macro-economic analysis Parent Market Analysis Market Overview Forecast Factors Segmental Analysis and Forecast Regional Analysis Competition Analysis

Target Audience Production Companies Suppliers Channel Partners Marketing Authorities Subject Matter Experts Research Institutions Financial Institutions Market Consultants Government Authorities

Market Taxonomy

The global canine stem cell therapy market has been segmented into:

Product Type: Allogeneic Stem Cells Autologous Stem cells

Application: Arthritis Dysplasia Tendonitis Lameness Others

End User: Veterinary Hospitals Veterinary Clinics Veterinary Research Institutes

Region: North America Latin America Europe Asia Pacific Japan Middle East & Africa

Buy Full Report at https://www.xploremr.com/cart/2360/SL

About Us

XploreMR, a leading market research firm, headquartered in San Jose, USA, XploreMR has, in a short span of time, served the market research needs of some of the biggest Fortune 500 companies. XploreMR also has highly personalized market research offerings for SMEs, and we pride ourselves on being uniquely positioned to have worked with colossal multinational firms and small, boutique firms. Our experience of working with such a diverse set from all over the world has given us invaluable perspectives on objectives, outlooks, goals, and eventually, the collective, symbiotic growth that stakeholders across the value chain aspire for. We keep these perspectives and aspirations in mind every time we work on a project, and this motivates us to exceed client expectations on a consistent basis.

Contact us:XploreMR111 North Market Street, Suite 300,San Jose, CA 95113, United StatesPh.No: +16692840108E-mail id- [emailprotected]Web- https://www.xploremr.com

Follow this link:

Canine Stem Cell Therapy Market Segment Analysis by Leading Players, Drivers, Regional, Competitive Landscape & Forecast To 2019 2029 - Owned

Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy – Cambridge Network

Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and reagents, is pleased to announce an expansion of its collaboration and licence agreement with Daewoong Pharmaceutical Co. Ltd. (KSX: 069620) and AffyXell Therapeutics, the joint venture established in South Korea by the two companies, to develop stem cell treatments incorporating Avactas neutralising Affimer therapy for the treatment of seriously ill patients with COVID-19 and to also prepare to rapidly develop similar therapies for future global pandemics.

Respiratory diseases such as COVID-19 can cause serious damage to the lungs as a consequence of over-activation of the patient's immune system, resulting in cytokine release syndrome that can potentially lead to multiple organ failure and death. Stem cell therapies offer a very promising approach to repair the damage to lung tissues in these pulmonary diseases by controlling the immune balance.

AffyXell Therapeutics, the next-generation cell and gene therapy joint venture between Avacta and Daewoong Pharmaceutical, is developing a novel class of mesenchymal stem cell (MSC) treatments that are engineered to also produce Affimer therapies in the patient at the site of action.

The expansion of the agreement between Avacta, Daewoong Pharmaceutical and AffyXell announced today extends the scope of the partnership to include Affimer molecules that target viruses, such as coronaviruses, in order to develop therapies that repair the lung damage caused by COVID-19 whilst also producing neutralising Affimer molecules to prevent the progression of the disease.

AffyXell will engineer mesenchymal stem cells to express SARS-COV-2 neutralising Affimer molecules in order to develop treatments for seriously ill COVID-19 patients, and will also prepare for rapid development of next-generation stem cell therapies for future infectious respiratory disease outbreaks.

Dr Alastair Smith, Chief Executive of Avacta Group commented: I am very pleased to have extended our collaboration and licence agreement with Daewoong Pharmaceutical to include the SARS-COV-2 neutralising Affimer molecules for the treatment of COVID-19 and to create the potential to respond very rapidly in future to global virus threats.

"AffyXell will address the need over the coming years for advanced stem cell therapies to treat lung damage caused by cytokine release syndrome suffered by COVID-19 patients and, at the same time, help prevent disease progression in these patients through the action of a neutralising Affimer therapy.

"More broadly, one of the key areas of unmet clinical need that AffyXell can address with its next-generation mesenchymal stem cell therapies is acute pulmonary diseases such as COPD and acute respiratory distress syndrome. We, and our partners in South Korea, are very excited by the potential to develop life improving treatments for patients with these serious respiratory diseases as well as COVID-19.

"I look forward to further updating the market on progress in our ground-breaking programmes with AffyXell in due course, and on progress with our COVID-19 diagnostics programmes shortly.

Seng-ho Jeon, CEO of Daewoong Pharmaceutical and AffyXell Therapeutics, commented: It is very encouraging that AffyXell now has the opportunity to expand the application of its next-generation stem cell platform technology to target viruses. The SARS-COV-2 neutralising Affimer to be developed in combination with AffyXells cell and gene technology is expected to be an innovative solution for COVID-19 patients suffering cytokine release syndrome.

"Daewoong has been also conducting several research programs and clinical trial for COVID-19. As the COVID-19 crisis has caused great difficulties worldwide, we will continue to focus our efforts to develop a novel therapeutic agent for COVID-19.

This announcement contains information which, prior to its disclosure, was considered inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 (MAR).

See the rest here:

Avacta and Daewoong Pharmaceutical expand partnership to include COVID-19 neutralising Affimer therapy - Cambridge Network

Impact of COVID-19 on Cell Freezing Media for Cell Therapy Market Overview with Detailed Analysis, Competitive Landscape & Forecast To 2026 -…

Innovative Report on Cell Freezing Media for Cell Therapy Market with Competitive Analysis, New Business Developments, and Top Companies

A perfect mix of quantitative & qualitative Cell Freezing Media for Cell Therapy Market Market information highlighting developments, industry challenges that competitors are facing along with gaps and opportunities available and would trend in Cell Freezing Media for Cell Therapy Market. The study bridges the historical data from 2014 to 2019 and estimated until 2026.

Prominent players profiled in the study: BioLife Solutions, Akron Biotechnology, GE Healthcare, Thermo Fisher Scientific, Biological Industries, Merck, WAK-Chemie Medical, Zenoaq

Sample Report with Latest Industry Trends @https://www.acquiremarketresearch.com/sample-request/379423/

Covid-19 pandemic affects most industries in the globe. Here at acquire market research we offer you comprehensive data of related industry which will help and support your business in all possible ways.

This Report Provides an overview of the Cell Freezing Media for Cell Therapy market, containing global revenue, global production, sales, and CAGR. Also describe Cell Freezing Media for Cell Therapy product scope, market overview, market opportunities, market driving force, and market risks. The forecast and analysis of the Cell Freezing Media for Cell Therapy market by type, application, and region are also presented. The next part of the report provides a full-scale analysis of Cell Freezing Media for Cell Therapy competitive situation, sales, revenue and global market share of major players in the Cell Freezing Media for Cell Therapy industry. The basic information, as well as the profiles, applications, and specifications of products market performance along with Business Overview, are offered.

With FBS, Without FBS: With FBS, Without FBS

Application: Human Embryonic Stem Cells, CAR-T Cell Therapy, Neural Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Hematopoietic Stem Cell Transplantation, Other

Geographical Regions: North America, Europe, Central & South America, Asia-Pacific, and the Middle East & Africa, etc.

Get Reasonable Discount on this Premium Report @https://www.acquiremarketresearch.com/discount-request/379423/

Scope of the Cell Freezing Media for Cell Therapy Report:

Worldwide Cell Freezing Media for Cell Therapy Market 2020, Market Size Value CAGR (XX %) and revenue (USD Million) for the historical years (2016 to 2019) and forecast years (2020 to 2026), with SWOT analysis, Industry Analysis, Demand, Sales, Market Drivers, Restraints, Opportunities and Forecast to 2026 cover in this research report.

As a part of our Corporate Social Responsibility, we would like to announce that we would be contributing 15 % of our profits to USA, UK, Italy, Spain and India relief fund.

This report covers the current scenario and growth prospects of the Cell Freezing Media for Cell Therapy Market for the period 2020-2026. The study is a professional and in-depth study with around tables and figures which provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the domain.

Finally, all aspects of the Global Cell Freezing Media for Cell Therapy Market are quantitatively as well qualitatively assessed to study the Global as well as regional market comparatively. This market study presents critical information and factual data about the market providing an overall statistical study of this market on the basis of market drivers, limitations and future prospects.

Browse Full [emailprotected] https://www.acquiremarketresearch.com/industry-reports/cell-freezing-media-for-cell-therapy-market/379423/

About us:

Acquire Market Research is a market research-based company empowering companies with data-driven insights. We provide Market Research Reports with accurate and well-informed data, Real-Time with Real Application. A good research methodology proves to be powerful and simplified information that applied right from day-to-day lives to complex decisions helps us navigate through with vision, purpose and well-armed strategies. At Acquire Market Research, we constantly strive for innovation in the techniques and the quality of analysis that goes into our reports.

Contact Us:

Sally Mach555 Madison Avenue,5th Floor, Manhattan,New York, 10022 USAPhone No.: +1 (800) 663-5579Email ID: [emailprotected]

Read this article:

Impact of COVID-19 on Cell Freezing Media for Cell Therapy Market Overview with Detailed Analysis, Competitive Landscape & Forecast To 2026 -...

Stem Cell Therapy Market Analysis and Forecast 2019 | By Top Players Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc.,…

A new business intelligence report released by CMI with title GlobalStem Cell Therapy MarketResearch Report 2019-2027 is designed covering micro level of analysis by manufacturers and key business segments. The Global Stem Cell Therapy Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing. Some of the key players profiled in the study are Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc.

Whats keeping Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc. Ahead in the Market? Benchmark yourself with the strategic moves and findings recently released by CMI

Leading players of Stem Cell Therapy Market:

Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc., JCR Pharmaceuticals Co., Ltd., Anterogen Co. Ltd., Pharmicell Co., Inc., and Stemedica Cell Technologies, Inc.

Stem Cell Therapy Geographical Segmentation Includes:

North America (U.S., Canada, Mexico)

Europe (U.K., France, Germany, Spain, Italy, Central & Eastern Europe, CIS)

Asia Pacific (China, Japan, South Korea, ASEAN, India, Rest of Asia Pacific)

Latin America (Brazil, Rest of L.A.)

Middle East and Africa (Turkey, GCC)

The research report includes an exploration of the competitive landscape present in the Stem Cell Therapy Market. It includes an import of the current and future trends that players can invest in. Likewise, it also includes an estimation of the business outlooks of the players and explains the nature of the competition.

Stem Cell Therapy Market Segmentation

By Cell Source:Adult Stem CellsInduced Pluripotent Stem CellsEmbryonic Stem CellsOthersGlobal Stem Cell Therapy Market, By Application:Musculoskeletal DisordersWounds and InjuriesCancerAutoimmune disordersOthers

The plus point of this research study is that it includes the impact of COVID-19 to the Stem Cell Therapy market. The data summarized within this research study includes forecast from 2020 to 2027. COVID-19 has significantly impacted each and every market on the global platform. If you have any specific requirement then Please get in touch with us. Our Expert team will provide as per report customized to your requirement.

Important Features of the report:

Reasons for buying this report:

It offers the regional analysis of the Stem Cell Therapy Market along with the business profiles of several stakeholders.

Some Major TOC Points:

Chapter 1. Stem Cell Therapy Market Report Overview

Chapter 2. Stem Cell Therapy industry Growing Trends

Chapter 3. Market Share by Key vendors

Chapter 4. Stem Cell Therapy Market Breakdown Data by Type and Application

Chapter 5. Stem Cell Therapy Market by End Users/Application

Chapter 6. COVID-19 Outbreak: Stem Cell Therapy Industry Impact

Chapter 7. Opportunity Analysis in Covid-19 Crisis

Chapter 9. Market Driving Factors

And Many More

Apply Promo Code CMIFIRST1000 And Get Instant Discount OfUSD 1000

Download PDF Brochure Of this Report @https://www.coherentmarketinsights.com/insight/request-pdf/2848

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, LATAM, West Europe, MENA Countries, Southeast Asia or Asia Pacific.

About us:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contacts US

Mr. ShahUS +1-206-701-6702/UK +44-020 8133 4027Email: [emailprotected]

The rest is here:

Stem Cell Therapy Market Analysis and Forecast 2019 | By Top Players Magellan, Medipost Co., Ltd, Osiris Therapeutics, Inc., Kolon TissueGene, Inc.,...

Family need to raise 120K by September for lifesaving treatment for 11-year-old – Cheshire Live

The family of a brave 11-year-old Wistaston boy needs to raise 120,000 by September so he can have lifesaving treatment in Asia to stop a rare form of bone cancer returning.

Georgy Capener was diagnosed with the highly malignant Ewings Sarcoma after a fall in a friends back garden on Easter Sunday in 2018.

Since then the plucky Wistaston Church Lane pupil has undergone numerous rounds of high dose aggressive chemotherapy and radiotherapy.

As a result of the treatment he lost his right arm which has been replaced a titanium prosthesis.

Georgy went into remission in March of last year and life returned to a semblance of normality for the Crewe boy, his mum Helen, dad Richard, and sisters Ellie, 18, and Chloe, 13.

But in April this year the family were dealt another devastating blow when they learned the cancer had returned - this time in Georgys left sinus, just under his eye socket and in the back of his nose.

Helen told CheshireLive: Everything had been going really well and then there was the impact of the coronavirus pandemic so one scan [to check Georgy] was moved further on but we never got to it because he started having really painful headaches. I knew something wasnt right.

Georgys parents were told that, because of the location of the tumour, there was a chance he could lose his eyesight or suffer a stroke during the biopsy he needed.

Helen told how, at first, she didnt want him to have the biopsy, but she knew he had to.

We didnt know if he was going to come out with his eyesight or have a stroke but he came through it, she said. Hes so brave, hes been so brave throughout.

Georgy, who is a passionate Liverpool fan, is now undergoing chemotherapy and radiotherapy again.

The tumour cannot be removed surgically because of its location.

But the vital stem cell therapy which is essential to ensure he can live a normal, healthy life and prevent the cancer returning at a later stage costs 130,000 and is not available for Georgy on the NHS.

Helen said: After lengthy discussions with a stem cell transplant hospital in a top medical treatment centre in Thailand, we are thrilled that they are willing to accept Georgy.

The transplant will involve removing the faulty mother cell and harvesting new purified cells from a donated umbilical cord into his body to stop the cancer from returning. These procedures have very high success rates.

Georgy is due to finish his sixth and final round of chemotherapy at the beginning of September.

For the stem cell treatment to be successful the procedure would have to start immediately after that to ensure the cancer doesnt return straight away.

The family has set up a JustGiving appeal to raise the funds needed to save their little boys life. They need to raise 120,000 by the beginning of September.

Helen said: We set it up in the hope that we can raise some of this amount to help save our sons life. It is our only realistic option and, for the first time in a long time, we can be positive and see some sort of future.

If you can help please donate by visiting JustGiving here.

Read more:

Family need to raise 120K by September for lifesaving treatment for 11-year-old - Cheshire Live

Peripheral Nerve Repair Devices Market Research Report by Device, by Application, by End User – Global Forecast to 2025 – Cumulative Impact of…

New York, July 29, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Peripheral Nerve Repair Devices Market Research Report by Device, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19" - https://www.reportlinker.com/p05941595/?utm_source=GNW

The Global Peripheral Nerve Repair Devices Market is expected to grow from USD 5,396.43 Million in 2019 to USD 11,283.48 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 13.08%.

Market Segmentation & Coverage:This research report categorizes the Peripheral Nerve Repair Devices to forecast the revenues and analyze the trends in each of the following sub-markets:

"The Neurostimulation & Neuromodulation Device is projected to witness the highest growth during the forecast period"

Based on Device, the Peripheral Nerve Repair Devices Market studied across Biomaterial and Neurostimulation & Neuromodulation Device. The Biomaterial further studied across Nerve Conduit, Nerve Connector, Nerve Protector, and Nerve Wrap. The Neurostimulation & Neuromodulation Device further studied across External Neurostimulation Device and Internal Neurostimulation Device. The Biomaterial commanded the largest size in the Peripheral Nerve Repair Devices Market in 2019. On the other hand, the Neurostimulation & Neuromodulation Device is expected to grow at the fastest CAGR during the forecast period.

"The Nerve Grafting is projected to witness the highest growth during the forecast period"

Based on Application, the Peripheral Nerve Repair Devices Market studied across Direct Nerve Repair/Neurorrhaphy, Nerve Grafting, Neurostimulation & Neuromodulation Surgery, and Stem Cell Therapy. The Direct Nerve Repair/Neurorrhaphy further studied across Epineural Repair, Group Fascicular Repair, and Perineural Repair. The Nerve Grafting further studied across Allograft, Autograft, and Xenograft. The Stem Cell Therapy commanded the largest size in the Peripheral Nerve Repair Devices Market in 2019. On the other hand, the Nerve Grafting is expected to grow at the fastest CAGR during the forecast period.

"The Ambulatory Surgery Center is projected to witness the highest growth during the forecast period"

Based on End User, the Peripheral Nerve Repair Devices Market studied across Ambulatory Surgery Center and Hospital & Clinic. The Hospital & Clinic commanded the largest size in the Peripheral Nerve Repair Devices Market in 2019. On the other hand, the Ambulatory Surgery Center is expected to grow at the fastest CAGR during the forecast period.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Peripheral Nerve Repair Devices Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Americas commanded the largest size in the Peripheral Nerve Repair Devices Market in 2019. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.

Company Usability Profiles:The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Peripheral Nerve Repair Devices Market including Axogen Inc., Baxter International, Boston Scientific Incorporation, Cyberonics Inc., GlaxoSmithKline Pharmaceuticals Ltd., Integra LifeSciences Corporation, Medovent GmbH, Medtronic PLC, NeuroMetrix, Inc., Orthomed S.A.S., Polyganics B.V., Renerva, LLC,, St. Jude Medical, Stryker Corporation,, Synovis Micro Companies Alliance, Inc., and Toyobo Co., Ltd..

FPNV Positioning Matrix:The FPNV Positioning Matrix evaluates and categorizes the vendors in the Peripheral Nerve Repair Devices Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Competitive Strategic Window:The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

Cumulative Impact of COVID-19:COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

The report provides insights on the following pointers:1. Market Penetration: Provides comprehensive information on the market offered by the key players2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:1. What is the market size and forecast of the Global Peripheral Nerve Repair Devices Market?2. What are the inhibiting factors and impact of COVID-19 shaping the Global Peripheral Nerve Repair Devices Market during the forecast period?3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Peripheral Nerve Repair Devices Market?4. What is the competitive strategic window for opportunities in the Global Peripheral Nerve Repair Devices Market?5. What are the technology trends and regulatory frameworks in the Global Peripheral Nerve Repair Devices Market?6. What are the modes and strategic moves considered suitable for entering the Global Peripheral Nerve Repair Devices Market?Read the full report: https://www.reportlinker.com/p05941595/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Excerpt from:

Peripheral Nerve Repair Devices Market Research Report by Device, by Application, by End User - Global Forecast to 2025 - Cumulative Impact of...

How Kaiser Permanente fights inequity in the face of COVID-19 – American Medical Association

Long-standing systemic health and social inequities have put members of racially and ethnically minoritized and marginalized communities at an increased risk for severe illness from COVID-19. With the disproportionate impact the pandemic has on Black, Latinx and other underserved communities, Kaiser PermanenteanAMA Health System Program Partnersends a clear message that the health program stands with those fighting for equity and justice.

We have a long-standing commitmentits in our DNAthat equity is important to us, said Edward M. Ellison, MD, a physician executive leading Permanente Medical Groups in Georgia and Southern California, and co-CEO of The Permanente Federation. It always has been equity, diversity and inclusion, and we recognize that there's more that we can do, and we want to do more.

In a recent call with Dr. Ellison, we discussed what Kaiser Permanente is doing to address inequities in health care. Here is what he had to say.

AMA: What inequities are driving the disproportionate impact of COVID-19 on Black and Latinx communities?

Dr. Ellison: Nationally it has been recognized that Black and Latinx communities have historically had increased challenges with access to health care in generalthe availability of proper nutrition, higher rates of preexisting conditions that we know predispose you to more significant outcomes with COVID-19, like heart disease, respiratory disease, diabetes, and there are other socioeconomic and environmental factors.

We also know the impact of ACEs [adverse childhood events] early in life and how that contributes to lifelong challenges with health, chronic stress, and what that can contribute to in terms of overall health.

In our country we've long had inequities in health care outcomes in Black, Latinx and underserved communities. COVID-19 has just exacerbated what we've observed in the past and highlighted the need to approach communities of color with targeted interventions to help us better serve and improve the outcomes, not just for COVID-19, but in all of the other areas.

Learn about five steps physicians can take to prioritize Black patients well-being.

AMA: What inspired Kaiser Permanentes 75-year commitment to equity and inclusion?

Dr. Ellison: I've been with the organization for 35 years and one of the things that drew meand kept me hereis I am inspired by the mission, vision and values of Kaiser Permanente. If you look at our mission, we are committed to providing high quality, affordable, accessible care for our members and the communities that we serve.

We have a history going back to the early days of Kaiser Permanente when Henry Kaiser declared that our hospitals would not be segregated. We want everyone to have equitable opportunities and recognized that with all thats going on in the country today, it was important to recommit. It was important to be public and make sure that all of our patients, our people, our communities knew where we stood. It was about how we've always had a long-standing commitment to closing gaps in health care inequities. We can always do better, but we've made a tremendous impact.

AMA: How do you help physicians and other health professionals maintain that commitment?

Dr. Ellison: One of the things that we have done is to embark on listening sessions. They have been powerful. I have appreciated the courage and the vulnerability of my Black colleagues and my Latinx colleagues who are sharing their experiences of discrimination and racism, and at times violence. There's so much for us to learn and so we want to use those learnings to help inform the actions that we take.

We participate in something called Hippocrates Circle, which includes our own physicians who have come from underserved populations and minority groups who found their own path through medicine to become physicians and overcame many obstacles. We affiliate with middle schools in underserved communities and students who self-identify as being interested in a career in medicine.

Kaiser Permanente sponsors fellowships for physicians to go into the community, identify need, and then help to address that need. There are many ways in which we try to help support our physicians and staff to stay connected to and understand how they can contribute and give back to the community.

We have something in Southern California called the Watts Counseling and Learning Center. It was founded in 1967, two years after the civil unrest in Watts and it started with just going out and meeting with mothers in the community.

We opened another facility, Baldwin Hills Crenshaw, in an underserved area in need of revitalization. We learned what they needed in the community and so when we built this facility, part of this almost nine-acre campus includes two and a half acres of green space and a two-mile walk.

They have this motto that health care is interwoven into people's daily lives, meeting people where they stand, and I think that's the philosophy that you take into making a difference in the communities. That particular facility was intentional40% of the contracts for building the building were to diverse businesses and companies owned by women, minorities, or veterans.

AMA: Are there different solutions for Latinx and Black communities, or does a broader solution work for all vulnerable communities?

Dr. Ellison: There are approaches that would be beneficial to all communities, including appropriate use of language, being culturally sensitive and responsive to different needs that different communities that we serve have, and understanding the impact of socioeconomic differences.

The cultural values for many Latinx patients and their families are gathering together, celebrating together, living in multi-generational households. But we know that is an added risk for COVID-19. We know that for the African American community, we have to work harder at building trust in the health care system because of past history.

We have to understand that there are actions we can take that are helpful, but it's not one size fits all. There are attributes beyond race that are impacted in terms of culture, socioeconomic conditions and educational background.

Learn about eight steps Kaiser Permanente is taking to suppress COVID-19.

AMA: During the COVID-19 pandemic with concerns about physical distancing, what ways have physicians continued to be involved in those communities?

Dr. Ellison: We've seen a tremendous acceleration of virtual care delivery of telemedicine both in terms of video and telephone, so understanding how you can meet the needs of the patient, even if it's virtually is really important. And those same cultural and language issues are just as important, if not more so.

Establishing a trusting relationship between the patient and the person providing care is really important and providing education to our physicians and other providers about how you can do that effectively, virtually. Then recognizing that not all of our members have access to virtual care.

Providing appropriate face-to-face care is still important but doing it in a safe way. Many of our patients want their care virtual right now for obvious reasons. And for those who need or desire face-to-face care, it's important that it's provided.

We worked hard to do outreach to our patients with communication about what's going on to reduce fear and uncertainty about the COVID virus, to get facts, to be as fact-based as possible, and to provide that in different languages so that we can make it easier for different communities to have the information that they need.

Learn more about helping patients put essential care ahead of COVID-19 fears.

AMA: Regarding staffing, how is Kaiser Permanente improving inclusiveness and diversity now and in the future?

Dr. Ellison: We're looking at how we recruit, how we develop individuals, how we provide opportunities for advancement. All of those are part of the work that we do, but I would say I'm very excited about the Kaiser Permanente School of Medicine.

In just a few weeks our first class of 50 students will be arriving. We took a very holistic approach in recruitment, so that we will be welcoming a class that does bring a diverse background and lived experiences.

We train a larger number of residents so after medical school, in a wide array of specialties, we have physicians being trained within our system and they're being exposed to the same vision, values and commitment in our organization.

It's also working with the communities and providing opportunities for minority-owned businesses to succeed. When we're contracting for services, were being intentional about providing opportunities from the communities that we serve.

AMA: Do you have any tips for other organizations that want to make a commitment to equity and inclusion?

Dr. Ellison: It starts with having a passionthat this is the right thing to do. I believe that it starts with the leadership of any organization. You have to create intentionality, be explicit in declaring what you value and why you value it. Create a safe space to execute on those values and create infrastructure that supports it and remove barriers to it.

The more of us that lean in together, the more successful that we'll be. But I do think it comes from also a place of humility knowing we don't have all the answers. It means listening to your peoplethey have the answers.

Whatever impact you can make, where you are with your opportunity, start there. Its about starting where you are and then reaching out and connecting. The more of us that do that, the more successful we'll be.

The AMA continues to compile criticalCOVID-19 health equity resourcesto shine a light on the structural issues that contribute to and could exacerbate already existing inequities. Physicians can also access the AMAsCOVID-19 FAQs about health equity in a pandemic.

Read the original post:

How Kaiser Permanente fights inequity in the face of COVID-19 - American Medical Association

Representative Bud Williams & Senator Nick Collins introduce Reparations Bill – BayStateBanner

Last week, legislators from opposite ends of the state filed a bill establishingthe Commonwealth Health, Economic, Education and Equity Recovery and Reconstruction Fund or CHEEERRS. Even before we learned of the economic and health inequities suffered by the Commonwealths Black and Latino residents exposed by COVID-19, we had ample evidence of the impact of yearsof systemic racial disparities that have been endured for far too long. This national and local reckoning presents a unique time for a reset. We begin the process with the filing of this bill.

State Representative Bud Williams (D-Springfield) and State Senator Nick Collins (D-Boston), have joined together to file this most bold piece of legislation. This bill supports close to $1 billion, identifies the source of funding, and establishes a separate independent bureau to oversee a comprehensive collection of services and programming directed to the targeted communities.

Even before the pandemic, our children, families, and businesses were struggling in what most would describe as a strong economy for everyone else. Its hard to imagine it could be worse when youre already hanging on by a thread. Yet, the pandemic has stretched the pain even further; our children are falling so far behind in school,were on pace to lose permanently much more than the projected 40% of Black and Latino business and weve represented more than 60% of the COVID-19 cases. stated Rep. Bud Williams. If there ever was a case to be made for a reset, for reparations, the time is now.

Among the highlights of the bill creates an independent bureau, support for families and children; a small business stabilization fund; support for returning citizens; a first in the nation resiliency service corps; and a process to review all the policies in the Executive Branch through a racial and social justice lens with an eye towards leveling the playing field.

After numerous conversations and listening sessions, I bear witness for those suffering due to the results of systemic racism, said Senator Nick Collins. It is impossible to miss and it is frightening to think as the dust eventually settles on the pandemic, it will likely be worse. It is clear, we must be intentional and bold in our efforts to tackle racial and economic injustice. This bill presents a real opportunity to address longstanding injustices, while providing assistance to communities who have been impacted the most by this pandemic. Stated Sen. Collins.

Weve seen corporate, spiritual and government leaders across the state posting Black Lives Matter signs on websites and issuing public statements of commitment to dismantle systemic racism, stated Horace Small, Founder and Director of the Union of Minority Neighborhoods. This bill is a huge step to making those words real.

Its no mystery to us that whether youre standing in Nubian Square in Roxbury or Mason Square in Springfield, the story is the same, our communities suffer the worse in nearly every health category, our children continue to learn in understaffed and under resourced school and our businesses are struggling stated Bishop Talbert Swan, President of the Springfield NAACP. Its unbelievable to think, as we begin to think about post pandemic life, that it could be worse. Its time to make the promise real.

There are also plans and activities happening across the state to create an external, sustained fund to complement and support the work of this bill. Were committed to a sustained effort stated Priscilla Flint Banks, Convenor of the Boston Black COVID-19 Coalition, a group of more than 70 organizations, businesses and individuals whove waged a fierce battle to ensure that resources are committed to Black and Latino neighborhoods, including contracting opportunities to for Black and Latino businesses. We spent 8 weeks to get mobile COVID-19 testing done in one neighborhood even after the state identified it as a hotspot! Black and Latino businesses got less than 2% of Bostons contracts and even less of the states contracts over the last 3 months. An extraordinary failure given that all bidding processes have been suspended since the Governor declared the health emergency in March! Weve earned a reset. The time is now. The CHEEERRS bill is a real first step!

Rep. Williams and Sen. Collins hope to move this bill on an expedited schedule.

View original post here:

Representative Bud Williams & Senator Nick Collins introduce Reparations Bill - BayStateBanner

NJBIZ panel: Diversity is organic, but inclusion is intentional – NJBIZ – NJBIZ

At the intersection of the COVID-19 pandemic and the national conversation on systemic racism brought on by the killing of George Floyd and protests thereafter, awareness and acknowledgment brings credibility to an organization, Senior Vice President of Human Resources for Delta Dental of New Jersey and Delta Dental of Connecticut Claude Richardson explained during an NJBIZ webinar panel discussion on diversity in the workplace on Tuesday.

If you appear to be tone-deaf to whats going on, if you appear to be tone-deaf to the plight of others in your organization, youre going to lose credibility of your workforce that you understand what it is that theyre going through, what their needs are, and that you perhaps even have their best interests at heart, Richardson said.

Agudosi

Richardson was joined by fellow panelists Amy Flynn, human resources specialist for HR business Insperity; Hackensack Meridian Health Director Diversity and Inclusion Avonia Richardson-Miller; and Genova Burns LLC Partner Rajiv Parikh to discuss how diversity and inclusion have become centrally important in todays business world.

New Jersey Office of Diversity and Inclusion Chief Diversity Officer Hester Agudosi moderated the discussion.

D&I is at the forefront of everything and at the core of everything right now, more than ever, Richardson-Miller said, noting the disparate impact of COVID-19 on communities of color, specifically Black communities; and her and other CEOs responses to the killing of George Floyd.

Richardson-Miller

HMH Chief Executive Officer Robert Garrett put out a statement on Floyds death, unarmed at the hands of a police officer in Minneapolis, shortly after it happened. His statement was compassionate, Richardson-Miller said, and really acknowledged what was going on and [had] a level of empathy and cultural intelligence around what the team members within the organization were feeling. His statement wasnt just a statement, she said, importantly, he also made a commitment to action going forward.

Parikh noted that an organizations leadership team should have goals with their D&I work, rather than just conversations; and that the goals arent one size fits all.

Parikh

Everybody knows you have to have them and you should have them, but at the end of those conversations, what do you want to have as your goal? Do you want a more communicative workforce? Do you want less tension, he said. Theres a question [in the Q&A] about internal staff division Do you want to try to alleviate that type of staff division? I think that all of those goals can be accomplished just, you know, by creating kind of a custom methodology for your organization.

Flynn noted that, with COVID-19, it may seem hard for organizations to put a timeline to the implementation of D&I policies and programs.

I know some of our clients are overwhelmed and thinking, this is massive. How am I going to accomplish all of this? she said. Her advice? Start somewhere.

Be able to start with a couple of initiatives that we think, okay, I can start with this and then we keep growing, she said. But really being able to make that commitment.

Part of D&I is managers or employers making sure theyre amplifying diverse voices.

In the age of the perpetual Zoom meeting, Richardson noted that while someone might have something valuable and constructive to offer, being reserved and having others chime in might dissuade them from doing so. Richardson recommends managers go around the squares of any Zoom call, giving participants the opportunity to share what they wanted to but didnt get to.

Richardson

Especially if they know in your meeting thats a routine of yours on and they definitely dont miss the opportunity to contribute, he said. [It helps them] not to be tone-deaf whats going on and helping them to express kind of where do we stand as an organization? and making sure that we dont lose the voice of those that may not otherwise speak up in this type of environment is really important.

As many companies continue to work partially or fully remote, keeping employees connected to one another is a challenge. Flynn suggested that employers offer their employees the chance to come together for varied discussion groups, and shared that one of the employers she works with has started a book group.

After all, the business case for focusing on diversity and inclusion is manifold: According to census data, Agudosi noted that New Jersey is on track to be majority minority in 20 years, banks that had a higher percentage of women on their boards fared better than their peers during the financial downturn of 2008, and diverse companies are more adaptive and innovative than their counterparts.

Flynn

According to Flynn, close to 70 percent of job seekers now are seeking out employers that make D&I a priority.

A webinar attendee from a mid-size conservation-based nonprofit told the panelists during Q&A that his or her organization was having trouble recruiting Black and Latinx people, and asked what could be done to attract that talent.

Richardson-Miller asked them if they were reaching out to historically black colleges and universities (HBCUs), Hispanic-serving institutes, and Black MBAs or Latino MBAs.

What are your intentional efforts in going after this talent? I think that there just has to be a very thoughtful methodical and intentional approach and making sure that your recruitment efforts are targeting agencies and organizations where that talent exists and where you can connect with that talent, she said.

Everyone matters. Diversity is organic, but inclusion is intentional, Agudosi said.

Read the original:

NJBIZ panel: Diversity is organic, but inclusion is intentional - NJBIZ - NJBIZ

The difference between conspiracies and disinformation – Fast Company

The COVID-19 pandemic has spawned an infodemic, a vast and complicated mix of information, misinformation, and disinformation.

In this environment, false narrativesthe virus was planned, that it originated as a bioweapon, that COVID-19 symptoms are caused by 5G wireless communications technologyhave spread like wildfire across social media and other communication platforms. Some of these bogus narratives play a role in disinformation campaigns.

The notion of disinformation often brings to mind easy-to-spot propaganda peddled by totalitarian states, but the reality is much more complex. Though disinformation does serve an agenda, it is often camouflaged in facts and advanced by innocent and often well-meaning individuals.

As a researcher who studies how communications technologies are used during crises, Ive found that this mix of information types makes it difficult for people, including those who build and run online platforms, to distinguish an organic rumor from an organized disinformation campaign. And this challenge is not getting any easier as efforts to understand and respond to COVID-19 get caught up in the political machinations of this years presidential election.

Rumors are, and have always been, common during crisis events. Crises are often accompanied by uncertainty about the event and anxiety about its impacts and how people should respond. People naturally want to resolve that uncertainty and anxiety, and often attempt to do so through collective sensemaking. Its a process of coming together to gather information and theorize about the unfolding event. Rumors are a natural byproduct.

Rumors arent necessarily bad. But the same conditions that produce rumors also make people vulnerable to disinformation, which is more insidious. Unlike rumors and misinformation, which may or may not be intentional, disinformation is false or misleading information spread for a particular objective, often a political or financial aim.

Disinformation has its roots in the practice of dezinformatsiya used by the Soviet Unions intelligence agencies to attempt to change how people understood and interpreted events in the world. Its useful to think of disinformation not as a single piece of information or even a single narrative, but as a campaign, a set of actions and narratives produced and spread to deceive for political purpose.

Lawrence Martin-Bittman, a former Soviet intelligence officer who defected from what was then Czechoslovakia and later became a professor of disinformation, described how effective disinformation campaigns are often built around a true or plausible core. They exploit existing biases, divisions, and inconsistencies in a targeted group or society. And they often employ unwitting agents to spread their content and advance their objectives.

Regardless of the perpetrator, disinformation functions on multiple levels and scales. While a single disinformation campaign may have a specific objectivefor instance, changing public opinion about a political candidate or policypervasive disinformation works at a more profound level to undermine democratic societies.

Distinguishing between unintentional misinformation and intentional disinformation is a critical challenge. Intent is often hard to infer, especially in online spaces where the original source of information can be obscured. In addition, disinformation can be spread by people who believe it to be true. And unintentional misinformation can be strategically amplified as part of a disinformation campaign. Definitions and distinctions get messy, fast.

Consider the case of the Plandemic video that blazed across social media platforms in May 2020. The video contained a range of false claims and conspiracy theories about COVID-19. Problematically, it advocated against wearing masks, claiming they would activate the virus, and laid the foundations for eventual refusal of a COVID-19 vaccine.

Though many of these false narratives had emerged elsewhere online, the Plandemic video brought them together in a single, slickly produced 26-minute video. Before being removed by the platforms for containing harmful medical misinformation, the video propagated widely on Facebook and received millions of YouTube views.

As it spread, it was actively promoted and amplified by public groups on Facebook and networked communities on Twitter associated with the anti-vaccine movement, the QAnon conspiracy theory community, and pro-Trump political activism.

But was this a case of misinformation or disinformation? The answer lies in understanding howand inferring a little about whythe video went viral.

The videos protagonist was Dr. Judy Mikovits, a discredited scientist who had previously advocated for several false theories in the medical domainfor example, claiming that vaccines cause autism. In the lead-up to the videos release, she was promoting a new book, which featured many of the narratives that appeared in the Plandemic video.

One of those narratives was an accusation against Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases. At the time, Fauci was a focus of criticism for promoting social distancing measures that some conservatives viewed as harmful to the economy. Public comments from Mikovits and her associates suggest that damaging Faucis reputation was a specific goal of their campaign.

In the weeks leading up to the release of the Plandemic video, a concerted effort to lift Mikovitss profile took shape across several social media platforms. A new Twitter account was started in her name, quickly accumulating thousands of followers. She appeared in interviews with hyperpartisan news outlets such as The Epoch Times and True Pundit. Back on Twitter, Mikovits greeted her new followers with the message: Soon, Dr Fauci, everyone will know who you really are.

More recently, Sinclair Broadcast Group, which owns or operates 191 local television stations across the country, had planned to air an interview with Mikovits in which she reiterated the central claims in Plandemic. In airing this program, Sinclair would have used the cover and credibility of local news to expose new audiences to these falseand potentially dangerousnarratives. The company is reconsidering its decision after receiving criticism; however, the interview was reportedly posted for a time on the companys website and was aired by one station.

This background suggests that Mikovits and her collaborators had several objectives beyond simply sharing her misinformed theories about COVID-19. These include financial, political, and reputational motives. However, it is also possible that Mikovits is a sincere believer of the information that she was sharing, as were millions of people who shared and retweeted her content online.

In the United States, as COVID-19 blurs into the presidential election, were likely to continue to see disinformation campaigns employed for political, financial, and reputational gain. Domestic activist groups will use these techniques to produce and spread false and misleading narratives about the diseaseand about the election. Foreign agents will attempt to join the conversation, often by infiltrating existing groups and attempting to steer them toward their goals.

For example, there will likely be attempts to use the threat of COVID-19 to frighten people away from the polls. Along with those direct attacks on election integrity, there are likely to also be indirect effectson peoples perceptions of election integrityfrom both sincere activists and agents of disinformation campaigns.

Efforts to shape attitudes and policies around voting are already in motion. These include work to draw attention to voter suppression and attempts to frame mail-in voting as vulnerable to fraud. Some of this rhetoric stems from sincere criticism meant to inspire action to make the electoral systems stronger. Other narratives, for example unsupported claims of voter fraud, seem to serve the primary aim of undermining trust in those systems.

History teaches that this blending of activism and active measures, of foreign and domestic actors, and of witting and unwitting agents, is nothing new. And certainly the difficulty of distinguishing between these is not made any easier in the connected era. But better understanding these intersections can help researchers, journalists, communications platform designers, policymakers, and society at large develop strategies for mitigating the impacts of disinformation during this challenging moment.

Kate Starbird is an associate professor of human-centered design and engineering at the University of Washington. This article is republished from The Conversation under a Creative Commons license. Read the original article.

Read more here:

The difference between conspiracies and disinformation - Fast Company

Creating a Tournament of Roses that celebrates the diversity of Southern California – OCRegister

History can be a powerful teacher, even when it involves a Rose Bowl queen.

Back in 1957, the Tournament of Roses named Joan Williams as Miss Crown City, the predecessor to the current Rose Queen. Then officials learned that she was African American and suddenly the city curtailed official duties of the honoree, according to an obituary for Williams, who died last year at age 86.

She was not invited to ride on a parade float. In fact, that year Pasadena decided against entering a float in the parade at all.

But in 2015 58 years later the city extended an apology and offered Williams an invitation to ride in the first float of the storied parade.

For 130 years, the spectacle on the first day of every new year has captured the attention of millions of people around the world. The parade was started as a showcase of sorts of the abundance provided by California weather, and also of its benefactors, the stalwart Pasadena scions who created it. For most of its history, the Tournament of Roses, which includes a foundation and committees that consist of volunteer members, reflected the epitome of Pasadenas old guard the white and male establishment.

In recent years, the organization has moved forward in fits and starts on its way to reflecting the Pasadena of today diversifying the ranks of volunteers, committee members and staff who keep it going. Its membership has grown to include more African Americans, Latinx and Asians, according to numbers provided by the organization.

As the community has become more diverse, so have the efforts to make the membership reflect that, says Tournament of Roses CEO David Eads.

Those efforts include adding at-large committee members who are ethnically diverse, says Laura Farber, the organizations immediate past president. Farber was the organizations first Latinx president; her term ended with the most recent festivities in January. She now chairs the committee that oversees football game management, a position never before held by a woman.

The committees are the pipeline by which executives, officers and presidents are promoted. All those who have served as president have come up through the committee system after years of service. The at-large members are chosen for their diversity.

I think that was intentional, observes Farber, an immigrant from Buenos Aires. We can at least make sure we are providing an opportunity to people from a variety of viewpoints. I credit the at-large positions for diversifying the organization.

The Tournament of Roses 935 members now number more women than men and are younger 43 is the average age of the latest class, Eads says. Its members are 11% African American, 20% Latinx and 20% Asian. Pasadena residents overall are almost 10% African American, 34.4% Latinx, 16% Asian and 36.5% white.

The committees oversee all the activities and the foundation that donates $200,000 to local nonprofits annually. They are what helped promote the Tournament of Roses first Asian American president in 2014, the first African American president two years ago and Farber one year ago.

An attorney with Pasadena law firm Hahn & Hahn, Farber says she first learned of opportunities to volunteer with the Tournament of Roses from other attorneys at the firm. She had never thought about it because she had the impression she would not be welcome.

Of course I would have never envisioned people like myself getting involved, she says. Im glad that I was encouraged to do so.

Farber has served on nine committees over 26 years and believes its important for young people from all walks of life and all socio-economic backgrounds to see people of color in prominent positions. With that in mind, she made a point to visit all of Pasadenas public schools and different community groups to invite them to visit the Rose Bowl headquarters while she was president.

You need experience to lead, she says. It took time. It took an investment. We are reaping the fruits now of the work we did over many years to bring this change.

Farbers notable contributions to the organization included bringing on three Latinas as grand marshals of the parade, something that had never been done before. Actresses Rita Moreno and Gina Torres joined Olympic gymnast Laurie Hernandez for the festivities this past January.

Farber also opened up the parade entries to a more global audience, which brought in bands and floats from countries that had never participated before.

Farber and Eads made it their goal to broaden the organizations membership, to bring in many different groups within the community, not just ethnically diverse groups and women.

Farber says she wants people from all economic classes to feel welcome to the festivities and to Wrigley Mansion, the Tournament of Roses headquarters. She has joined committees with the local NAACP to help businesses during the current economic downturn.

Farber wants to encourage participation so that more people who represent the community at large move into executive positions. Many members of the Tournament of Roses committees come from nonprofit organizations that work to support the community and create an overlap of interests.

The foundation grants $200,000 annually to nonprofit groups offering programs in education, sports and recreation, and the visual and performing arts. It offers a scholarship for high school football players nationwide and funds local nonprofits in their fundraising efforts.

To increase participation, Eads says the organization has participated in community parades and events, such as the Black History Parade, the Latino Heritage Parade and the San Gabriel Valley Pride Festival. It has been a deliberate effort, he says.

We continue to evolve. We try to keep a balance between holding on to our values. The joy and excitement of the Tournament of Roses and our traditions are only enhanced when we have an inclusive membership, Eads says.

But while there has been progress in reflecting the community, that progress should not be taken for granted, says former Pasadena developer Jim Morris, who once protested the lack of diversity of the Rose Bowl with an actual roadblock of the coronation festivities. He and other activists persisted in efforts to bring awareness to what they saw as stagnation in getting the organization to better reflect the community.

Morris fears there are efforts to eliminate those at-large positions that helped elevate Farber, Gerald Freeny, the first African American president, and Richard Chinen, the first Asian American president.

Morris also believes the foundation can do a better job of supporting local communities of color rather than donating to organizations in economically well-off cities such as San Marino and La Caada Flintridge.

Along with the encouraging changes brought on by diversifying the membership, Morris hopes that diversity broadens and that more history of the event be known that, for instance, the land on which the Rose Bowl and the Wrigley Mansion reside was once owned by an African American.

Morris is encouraged, however, to see the recent demands for structural change in the country and believes it will benefit all people if these changes are enacted.

Theres a hope that this change is going to be meaningful, he says, adding that when more people are included in organizations such as the Tournament of Roses, everybody benefits.

Eads too looks forward to seeing the tournament continue to embrace and reflect all people of Southern California today. It makes for a better organization. We are stronger for it.

Read more here:

Creating a Tournament of Roses that celebrates the diversity of Southern California - OCRegister

State hears testimony on closure of Holyoke Medical Center’s birthing center – GazetteNET

HOLYOKE When Jane Frey began working as a midwife in Holyoke in 1985, the citys infant mortality rate was the highest in the state.

As part of the Holyoke Infant Mortality Task Force, Frey and others worked with the Department of Public Health, or DPH, to take steps that significantly lowered that mortality rate. However, after Holyoke Medical Center recently announced that it intends to close its Birthing Center by Oct. 1, Frey is concerned that history might repeat itself.

I fear we are back to the beginning, Frey said Tuesday, speaking in front of the same state agency whose work with the task force led to the creation of the midwife practice at Holyoke Medical Center.

Freys comments came at a DPH hearing mandated as part of an essential service closure process that hospitals must complete before closing a unit. Holyoke Medical Center announced on May 29 that it planned to shutter its 13-bed obstetrics unit and 10-bassinet infant nursery services it had already temporarily ended in early April when it agreed to house patients from the Holyoke Soldiers Home during a massive coronavirus outbreak at that facility.

Beginning the hearing, HMC CEO Spiros Hatiras said that the medical center had previously closed birthing services in 1974 due to a low volume of births and that it only re-opened in 1993 because the hospital had lost contracts with two HMOs that insisted hospitals provide birthing services.

It was widely acknowledged that the reopening would be a risky move and would be unpopular with other providers in the area because there was no unmet need in the community for birthing services, Hatiras said.

Hatiras said that birthing volume has been below the hospitals target for nearly three decades and that a low volume does not allow providers to maintain their professional competencies. Hatiras also said the hospital has not received reports that patients, who are now being sent to Mercy Medical Center in Springfield, have had issues with accessing birthing services since the unit closed in April.

Holyoke Medical Center is only discontinuing birthing services at our facility, not all maternal services, Hatiras said. We have been and will continue to provide prenatal services, family planning services, GYN services and postpartum care.

Hatiras said the hospital has a transportation system for patients. He also said the hospital will continue to provide education, care and support for mothers and babies before and after birth, which he said are the most important factors for keeping infant mortality low.

Many speakers during the public hearing, however, expressed outrage over the decision to close the Birthing Center, the way the closure was handled and the effects they said it would have on the community.

I urge Mr. Hatiras and (head of womens services Marc) Zerbe to walk the two-mile climb from the Flats of Holyoke to the OB-GYN offices at Holyoke Medical Center, pushing a baby carriage or with other children in tow to see what it is like if you had no transportation, Frey said.

Frey added that when she recently called HMC to inquire about prenatal care, she was told there were only two OB-GYNs and one nurse midwife on staff, none of whom speak Spanish. She also said she was told obstetric care would be provided at HMC and that deliveries will be done at Mercy with providers patients have not met, she noted.

Many took issue with the way they said Birthing Center staffers were treated, which they said pointed to a systemic and intentional dismantling of midwifery and birthing services.

If the hospital had these concerns, never once did they truly share them with us, the people on the front lines, said Nina Kleinberg, a nurse midwife who worked at the practice from 1988 until 2019. Instead, they created a toxic atmosphere that made us want to leave, and thats why I dont trust their rationale.

Kleinberg was one of five former employees who spoke on the record for a Gazette investigation into the closure. The five women alleged that higher-ups engaged in bullying, intimidation and micromanagement of midwives and other staffers, pushing out many longtime employees in the process.

Despite what is being stated as low numbers, actually for our community hospital we were doing quite well and maintaining our numbers despite a plummeting birth rate in the nation as well as in the state of Massachusetts, said former HMC nurse midwife Vanessa Ross, who worked at the practice from 2006 until 2019. That administration systematically brought about the low numbers that you now see.

Ross and former nurse Lisa Pack Kirschenbaum, who worked at the Birthing Center for 26 years, challenged the assertion that a lower volume of births led staff to be less prepared for emergencies.

During his testimony, HMC Chief Medical Officer Simon Ahtaridis said that a low volume also meant the hospital only kept a small number of physicians on staff, which he said caused problems if somebody took time off for any reason.

Our patients and providers deserve better for that, and in partnering with Mercy our remaining two physicians will be able to join the Mercy team of nine physicians and provide more sustainable and stable coverage for urgencies and emergencies, Ahtaridis said.

For many speaking Tuesday, the closure of the Birthing Center represented a larger problem with health care in the region and country.

My concern is that the public health of individuals of our community, particularly in Holyoke, its always been considered due to revenue, said Ward 1 City Councilor Gladys Lebron-Martinez.

Patricia Duffy, who is running for the citys state representative seat, said city residents expressed concern that local control or other services may be lost at the hospital. Current state Rep. Aaron Vega, D-Holyoke, expressed frustration with a system that he said leaves the community hospital reliant on care packages from the federal government and last-minute bailouts by MassHealth to keep it afloat.

DPH now has 15 days to determine whether the services being closed are necessary for preserving access and health status within the hospitals service area. If deemed necessary, the hospital will have 15 days to submit a plan for assuring access.

However, that is the extent of the powers DPH has under state law. The state has no power to stop the closure or penalize the hospital for closing services, even if they are deemed essential. State Rep. Lindsay Sabadosa, D-Northampton, noted that fact in her comments Tuesday.

We see consistently programs taken apart piece by piece until they are no longer deemed essential, and that seems to happen more often than not in poor communities, it happens in communities of people of color and it seems to be real easy when women are involved, she said. And that is something that DPH along with the Legislature really is going to need to take a hard look at.

The rest is here:

State hears testimony on closure of Holyoke Medical Center's birthing center - GazetteNET

Women in Hip-Hop Cannot Thrive While Misogynoir Exists – HarpersBAZAAR.com

It was just the worst experience of my life. And its not funny. Its nothing to joke about. It was nothing for yall to start going and making fake stories about, said Megan Thee Stallion on Instagram Live, holding back tears as she addressed her shooting injuries. I didnt put my hands on nobody. I didnt deserve to get shot.

The men in the hip-hop community have failed Megan Thee Stallion. On social media she was mocked and memed, diminishing the gravity of violence enacted upon her. It points to a larger problem: the sadistic nature of misogynoir in hip-hop, an industry stained by the blood of violence against Black women by its forefathers.

Hip-hop, a genre born from the overt abuse and brutality Black communities have suffered by law enforcement, upholds the patriarchy. Its one of the few spaces where Black men can emulate the power ideals of whiteness. It's a developed framework that justifies Chris Browns existence on Billboards chart despite his physical assault of Rihanna in February 2009; instead of being held accountable by his peers, he was welcomed into a fraternity of success and masculinity built on the dehumanization of Black women. Its often said that Black women are fighting two wars based on the intersections of race and gender. Misogyny is institutional oppression against women at large, but misogynoir is the dehumanization of Black women perpetuated through individual, societal, and cultural violence toward Black women. Until men in hip-hop show genuine support and investment for Black women in hip-hop, the latter will never be granted justice, not even in death.

This content is imported from Twitter. You may be able to find the same content in another format, or you may be able to find more information, at their web site.

As Black women took to the streets to protest the death of Breonna Taylor, social media and blogs reduced their calls to justice for Taylors death to a superficial meme, a trend void of the richness and complexity of her life. When news broke about Megans attack, Twitter erupted with misogynistic memes from Black users centered on her ass, boobs, and knees, implying that the loss of her sexual appeal mattered more than her actual life. Her face was superimposed on Ricky Bakers (played by Morris Chestnut) when he is shot in the film Boyz N The Hood and Madame Vera Walkers (played by Della Reese) when her pinky toe is shot in Harlem Nights. The migration of memes across social media platforms reinforces the devaluation of Black women in celebrity and hip-hop culture, where their full humanity is reduced, sexualized, and rendered as one-dimensional.

One of the most compelling emcees and lyricists of her generation, Megan Thee Stallion is hip-hop's biggest star. She has accomplished world-wide success and renown for her explicit lyrics that put women in power, catering to their satisfaction and fulfillment as she raps about her player ways and skimpy clothes. Shes the Houston hottie with a model body, yet through a patriarchal lens, men in hip-hop seek to reconstruct her lyrics of empowerment as justification for objectifying her body as a holding place of male desire, rage, and violence.

Who hears a Black womans cries of fear and pain if their personhood is stripped away?

Who hears a Black womans cries of fear and pain if their personhood is stripped away? If Black women are no longer regarded as human, then their bodies are deemed deserving of disproportionate amounts of pain. If Black women are no longer granted femininity, then their bodies are subjected to transphobic attacks in an attempt to validate the violence they endure. Camron responded to Megans attack by reposting an Instagram post that said her shooter "saw that dick and started shootn..IDC what no one say. His commentary reflects a double standard in hip-hops misogynistic framework, one that awards male rappers for protecting themselves against an aggressive assailant but blames women for their hostile behavior that results in gun violence. 50 Cent, who survived being shot nine times (he references the attack on his hit Many Men (Wish Death) from his debut album Get Rich or Die Tryin), posted a meme about Megans injury, which he later apologized for and deleted after her Instagram Live session.

Megan Thee Stallion didnt deserve to get shot. Liza Rios didnt deserve to be hit by Big Pun. Dee Barnes didnt deserve to be attacked by Dr. Dre. Steph Lova didnt deserve to be harassed by DJ Funkmaster Flex. Linda Williams didnt deserve to be punched by Damon Dash. Lil Kim didnt deserve to be in a violent relationship with The Notorious B.I.G. Drew Dixon, Sil Abrams, Sherri Hines, and others didnt deserve to be sexually assaulted by Russell Simmons. (Simmons has denied the allegations.) Misogynoir is an intracommunal pandemic.

Its not the responsibility of Black women in hip-hop to address the racialized and sexual violence towards their community.

Oppressive structures are maintained by the erasure and intentional neglect of individuals who are disregarded and marginalized. In a white supremacist society, hip-hop is unique because of its existence as one of the few influential structures where cisgender heterosexual Black men can be in positions of power, but their silence toward Black women is reflective of the patriarchal systems they have upheld. Hip-hop has provided a space for Black men to build empires and legacies; Def Jam Recordings, Roc-A-Fella Records, and Bad Boy Records have affirmed Russell Simmons, Jay-Z, and Diddys places as worldwide ambassadors for hip-hop culture. Where was Jay-Z following Megans attack? She signed to Roc Nation management and collaborated with Beyonc on the Savage'' remix, but he said nothing. Where was Diddy? He featured her on his COVID-19 Dance-a-Thon, but he also said nothing. Though some men like Wale and 21 Savage showed their support, the majority of voices in hip-hop who displayed comfort and support for Megan Thee Stallion were Black women, who historically have shown up for themselves when no one else would.

Before the age of 25, Megan Thee Stallion had publicly lost her mother and grandmother. Yet during her ascension to stardom, and through her grief, she still continued to reach out and support Hotties with engagements on social media, charitable donations to her hometown of Houston, and a CashApp campaign. On her July 27 Instagram Live, her first appearance since the shooting, she continued to show that resilience, assuring us, A bitch is alive and well. Strong as fuck. Im ready to get back to regular programming with my hot girl shit.I cant keep putting my energy in a bunch of you motherfuckers.

Its not the responsibility of Black women in hip-hop to address the racialized and sexual violence towards their community. Black men in hip-hop need to participate in the disinvestment of misogyny in the culture, instead of silence. In order for Black women in hip-hop to live and thrive, the structure of misogynior must be abolished.

This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses. You may be able to find more information about this and similar content at piano.io

This commenting section is created and maintained by a third party, and imported onto this page. You may be able to find more information on their web site.

Continue reading here:

Women in Hip-Hop Cannot Thrive While Misogynoir Exists - HarpersBAZAAR.com

Monterey County joins in suing Trump administration over exclusion of undocumented immigrants in census. – Monterey County Weekly

The census happens every 10 years and is the federal government's process of data-gathering that guides all sorts of decisionssuch as how federal funds are allocated, and how congressional district lines are drawn and how much representation a region gets in Washington. And given those high stakes, President Donald Trump's efforts to exclude undocumented immigrants from the count have drawn immense backlash.

First, there was a proposal to include a new question:"Is this person acitizenof theUnited States?" Dozens of cities counties and states sued, arguing the question was contrived just for the purpose of intimidating non-citizens and discouraging them from completing the census. In June 2019, the U.S. Supreme Court ruled in the plaintiffs' favor, and the question was dropped.

Fast-forward to July 21, 2020, with the census in full swing.Trump issued a memo that would alter the definition of "whole persons" used in census-based calculations, excluding undocumented immigrants.

Cue another round of lawsuits, again filed by a large coalitionnine cities and six countiesagainstPresident Trump, the U.S. Department of Commerce, the U.S. Census Bureau, Commerce Secretary Wilbur Ross, and Census Director Steven Dillingham.

On July 28, the Monterey County Board of Supervisors voted to join that lawsuit.

As we continue to work hard to get an accurate count in the 2020 Census, we want to send a clear message to our communities: if you live here, you count, Chris Lopez, chair of the Board of Supervisors, said in a statement. Intentional and unconstitutional efforts to deter legal participation in the census will not go unchallenged. Our fair representation and equal access to funds depends on the census, we encourage every person living in Monterey County to stand up, log on, and get counted.

Read more:

Monterey County joins in suing Trump administration over exclusion of undocumented immigrants in census. - Monterey County Weekly